Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Morgan Roupret and Shahrokh Shariat.
Morgan Roupret
Connection Strength
4.302
Shahrokh Shariat
  1. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol. 2018 01; 73(1):111-122.
    View in: PubMed
    Score: 0.731
  2. The role for surgery in high-risk prostate cancer. Wien Med Wochenschr. 2015 Oct; 165(19-20):395-400.
    View in: PubMed
    Score: 0.320
  3. Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes. J Clin Med. 2019 Aug 09; 8(8).
    View in: PubMed
    Score: 0.209
  4. The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review. Urol Oncol. 2019 10; 37(10):659-671.
    View in: PubMed
    Score: 0.207
  5. Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer. Urol Oncol. 2019 10; 37(10):774-783.
    View in: PubMed
    Score: 0.207
  6. Role of serum cholinesterase in patients treated with salvage radical prostatectomy. Urol Oncol. 2019 02; 37(2):123-129.
    View in: PubMed
    Score: 0.199
  7. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus. 2020 11 15; 6(6):1233-1239.
    View in: PubMed
    Score: 0.199
  8. A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens. BJU Int. 2019 01; 123(1):11-21.
    View in: PubMed
    Score: 0.194
  9. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. Urol Oncol. 2018 04; 36(4):158.e1-158.e6.
    View in: PubMed
    Score: 0.187
  10. Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer. Clin Genitourin Cancer. 2018 06; 16(3):e619-e627.
    View in: PubMed
    Score: 0.185
  11. Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer. Clin Genitourin Cancer. 2017 Aug 15.
    View in: PubMed
    Score: 0.182
  12. Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy. Bladder Cancer. 2017 Jul 27; 3(3):161-169.
    View in: PubMed
    Score: 0.182
  13. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. Urol Oncol. 2016 May; 34(5):233.e1-6.
    View in: PubMed
    Score: 0.165
  14. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol. 2014 Nov; 66(5):913-9.
    View in: PubMed
    Score: 0.141
  15. Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol. 2013 Feb; 31(1):5-11.
    View in: PubMed
    Score: 0.130
  16. Intravesical therapy for bladder cancer in the pandemic of Covid-19. World J Urol. 2021 04; 39(4):1313-1314.
    View in: PubMed
    Score: 0.055
  17. The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead? Eur Urol. 2020 Jul; 78(1):124-126.
    View in: PubMed
    Score: 0.055
  18. What Is the Significance of Variant Histology in Urothelial Carcinoma? Eur Urol Focus. 2020 07 15; 6(4):653-663.
    View in: PubMed
    Score: 0.053
  19. Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails. Eur Urol. 2020 01; 77(1):1-2.
    View in: PubMed
    Score: 0.053
  20. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019 Nov; 76(5):639-657.
    View in: PubMed
    Score: 0.052
  21. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int. 2019 May 04.
    View in: PubMed
    Score: 0.051
  22. Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature. Urol Oncol. 2019 07; 37(7):430-436.
    View in: PubMed
    Score: 0.051
  23. Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel. Eur Urol Focus. 2020 05 15; 6(3):479-489.
    View in: PubMed
    Score: 0.050
  24. Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered? Eur Urol Focus. 2018 07; 4(4):525-528.
    View in: PubMed
    Score: 0.049
  25. Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art. Minerva Urol Nefrol. 2018 Jun; 70(3):242-251.
    View in: PubMed
    Score: 0.047
  26. Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016". Eur Urol Focus. 2019 05; 5(3):457-466.
    View in: PubMed
    Score: 0.047
  27. Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies. J Urol. 2018 05; 199(5):1149-1157.
    View in: PubMed
    Score: 0.046
  28. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. Eur Urol Focus. 2019 07; 5(4):681-688.
    View in: PubMed
    Score: 0.046
  29. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU Int. 2018 02; 121(2):252-259.
    View in: PubMed
    Score: 0.046
  30. Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study. Eur J Surg Oncol. 2017 Nov; 43(11):2193-2199.
    View in: PubMed
    Score: 0.046
  31. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. Eur Urol. 2017 11; 72(5):801-813.
    View in: PubMed
    Score: 0.045
  32. The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. Eur Urol Focus. 2016 Apr; 2(1):79-85.
    View in: PubMed
    Score: 0.039
  33. Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. Eur Urol. 2012 Dec; 62(6):1088-96.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.